Form 8-K - Current report:
SEC Accession No. 0001558370-23-011376
Filing Date
2023-06-23
Accepted
2023-06-23 16:05:20
Documents
13
Period of Report
2023-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230621x8k.htm   iXBRL 8-K 82983
2 EX-10.1 tmb-20230621xex10d1.htm EX-10.1 11601
  Complete submission text file 0001558370-23-011376.txt   217488

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20230621.xsd EX-101.SCH 3138
4 EX-101.LAB tmb-20230621_lab.xml EX-101.LAB 15267
5 EX-101.PRE tmb-20230621_pre.xml EX-101.PRE 9931
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230621x8k_htm.xml XML 4668
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 231037669
SIC: 2834 Pharmaceutical Preparations